Analysis of open access databases of the Kaplan–Meier plotter (http://kmplot.com/) and TCGA showed that BC and gastric cancer patients with higher TFCP2L1 expression had shorter overall survival (Fig EV3B–D). This evidence concerns the gene TFCP2L1 and gastric cancer.